These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2070049)

  • 1. Fibrinogen Kyoto II, a new congenitally abnormal molecule, characterized by the replacement of A alpha proline-18 by leucine.
    Yoshida N; Okuma M; Hirata H; Matsuda M; Yamazumi K; Asakura S
    Blood; 1991 Jul; 78(1):149-53. PubMed ID: 2070049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new congenital abnormal fibrinogen Ise characterized by the replacement of B beta glycine-15 by cysteine.
    Yoshida N; Wada H; Morita K; Hirata H; Matsuda M; Yamazumi K; Asakura S; Shirakawa S
    Blood; 1991 May; 77(9):1958-63. PubMed ID: 2018836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterozygous abnormal fibrinogen Osaka III with the replacement of gamma arginine-275 by histidine has an apparently higher molecular weight gamma-chain variant.
    Yoshida N; Imaoka S; Hirata H; Matsuda M; Asakura S
    Thromb Haemost; 1992 Nov; 68(5):534-8. PubMed ID: 1455400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen Magdeburg I: a novel variant of human fibrinogen with an amino acid exchange in the fibrinopeptide A (Aalpha 9, Leu-->Pro).
    Meyer M; Kutscher G; Stürzebecher J; Riesener G; Lutze G
    Thromb Res; 2003 Jan; 109(2-3):145-51. PubMed ID: 12706644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of an apparently lower molecular weight gamma-chain variant in fibrinogen Kyoto I. The replacement of gamma-asparagine 308 by lysine which causes accelerated cleavage of fragment D1 by plasmin and the generation of a new plasmin cleavage site.
    Yoshida N; Terukina S; Okuma M; Moroi M; Aoki N; Matsuda M
    J Biol Chem; 1988 Sep; 263(27):13848-56. PubMed ID: 2971046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen Birmingham: a heterozygous dysfibrinogenemia (A alpha 16 Arg----His) containing heterodimeric molecules.
    Siebenlist KR; Prchal JT; Mosesson MW
    Blood; 1988 Mar; 71(3):613-8. PubMed ID: 3345340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen Ledyard (A alpha Arg16----Cys): biochemical and physiologic characterization.
    Lee MH; Kaczmarek E; Chin DT; Oda A; McIntosh S; Bauer KA; Clyne LP; McDonagh J
    Blood; 1991 Oct; 78(7):1744-52. PubMed ID: 1912564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An apparently higher molecular weight gamma-chain variant in a new congenital abnormal fibrinogen Tochigi characterized by the replacement of gamma arginine-275 by cysteine.
    Yoshida N; Ota K; Moroi M; Matsuda M
    Blood; 1988 Feb; 71(2):480-7. PubMed ID: 3337908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinogen Kanazawa: a congenital dysfibrinogenaemia with delayed polymerization having a replacement of proline-18 by leucine in the A alpha-chain.
    Uotani C; Miyata T; Kumabashiri I; Asakura H; Saito M; Matsuda T; Kajiyama S; Iwanaga S
    Blood Coagul Fibrinolysis; 1991 Jun; 2(3):413-7. PubMed ID: 1932527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen Milano. VI: A heterozygous dysfibrinogenemia (A alpha 16 Arg----His) with bleeding tendency.
    Bögli C; Cofrancesco E; Cortellaro M; Della Volpe A; Hofer A; Furlan M; Zanussi C
    Eur J Haematol; 1990 Jul; 45(1):26-30. PubMed ID: 2379562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymerization defect of fibrinogen Baltimore III due to a gamma Asn308----Ile mutation.
    Bantia S; Bell WR; Dang CV
    Blood; 1990 Apr; 75(8):1659-63. PubMed ID: 2328317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An abnormal fibrinogen Fukuoka II (Gly-B beta 15-->Cys) characterized by defective fibrin lateral association and mixed disulfide formation.
    Kamura T; Tsuda H; Yae Y; Hattori S; Ohga S; Shibata Y; Kawabata S; Hamasaki N
    J Biol Chem; 1995 Dec; 270(49):29392-9. PubMed ID: 7493975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release.
    Yan J; Luo M; Cheng P; Liao L; Deng X; Deng D; Lin F
    Int J Hematol; 2017 Apr; 105(4):506-514. PubMed ID: 27933517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A congenitally abnormal fibrinogen (Vlissingen) with a 6-base deletion in the gamma-chain gene, causing defective calcium binding and impaired fibrin polymerization.
    Koopman J; Haverkate F; Briët E; Lord ST
    J Biol Chem; 1991 Jul; 266(20):13456-61. PubMed ID: 2071611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen Guarenas I: partial characterization of a new dysfibrinogenemia with an altered rate of fibrinopeptide release and an impaired polymerization.
    Lundberg UG; Rodriguez S; Marchi R; Ruiz-Saez A; Arocha-Piñango CL
    Thromb Res; 1995 Apr; 78(2):95-106. PubMed ID: 7482436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization.
    Tanaka H; Terasawa F; Ito T; Tokunaga S; Ishida F; Kitano K; Kiyosawa K; Okumura N
    Thromb Haemost; 2001 Jan; 85(1):108-13. PubMed ID: 11204560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen Alès: a homozygous case of dysfibrinogenemia (gamma-Asp(330)-->Val) characterized by a defective fibrin polymerization site "a".
    Lounes KC; Soria C; Mirshahi SS; Desvignes P; Mirshahi M; Bertrand O; Bonnet P; Koopman J; Soria J
    Blood; 2000 Nov; 96(10):3473-9. PubMed ID: 11071644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen Kyoto III: a congenital dysfibrinogen with a gamma aspartic acid-330 to tyrosine substitution manifesting impaired fibrin monomer polymerization.
    Terukina S; Yamazumi K; Okamoto K; Yamashita H; Ito Y; Matsuda M
    Blood; 1989 Dec; 74(8):2681-7. PubMed ID: 2819242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen Longmont. A heterozygous abnormal fibrinogen with B beta Arg-166 to Cys substitution associated with defective fibrin polymerization.
    Lounes KC; Lefkowitz JB; Coates AI; Hantgan RR; Henschen-Edman A; Lord ST
    Ann N Y Acad Sci; 2001; 936():129-32. PubMed ID: 11460470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of fibrinogen Naples associated with defective thrombin binding and thrombophilia. Homozygous substitution of B beta 68 Ala----Thr.
    Koopman J; Haverkate F; Lord ST; Grimbergen J; Mannucci PM
    J Clin Invest; 1992 Jul; 90(1):238-44. PubMed ID: 1634610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.